• Duphat
  • infinia camp
mededge mea logo web MedEdge_Logo_Dark

Public Relations, Top Health Magazine and Healthcare News GCC

  • Newsletters
  • Magazines
  • Subscribe
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
      • Healthcare Journals & Publishers
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Reading: New Hope for Malaria Control: Mozambique Introduces R21 Vaccine
Share
Notification
  • Duphat
  • infinia camp
mededge mea logo web
  • Magazines
  • Newsletters
  • Profiles
  • Subscribe
Search
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Have an existing account? Sign In
MedEdge MEA > Health For All > Women and Child Health > New Hope for Malaria Control: Mozambique Introduces R21 Vaccine
Women and Child Health

New Hope for Malaria Control: Mozambique Introduces R21 Vaccine

ME Desk
ME Desk
Published: August 8, 2024
Share
3 Min Read
Hope for Malaria Control: Mozambique Introduces R21 Vaccine
SHARE

Maputo- August 2024- Mozambique reached an important milestone in malaria prevention among children with the introduction of the R21 vaccine, which will help reduce malaria cases and save thousands of childrenโ€™s lives each year. In Africa, one child dies from malaria every minute.

Through Gavi, the Vaccine Alliance, and co-financing from the Government of Mozambique, the country has received about 800 000 malaria vaccine doses to vaccinate around 300 000 children through the countryโ€™s Expanded Programme on Immunization. The vaccine will cover 22 districts in Zambรฉzia province. Children aged 6 to 11 months will receive the first dose in a 4-dose schedule.

โ€œThe malaria vaccine, which is being rolled out initially in Zambezia today, is one of the latest approaches in the fight against the disease,โ€ said Hon Dr Armindo Tiago, Minister of Health. โ€œThe choice of Zambezia as the launch site is due to the high burden of the disease in the province. The vaccine will be administered in four doses with the aim of reducing the severe malaria illness and death.โ€

The WHO-recommended R21 vaccine is safe and effective. When provided in childhood immunization (programme?), it reduces over half of malaria cases (as high as 66%) in children during the first year of follow-up and prolonged protection with the fourth dose of vaccine. Moreover, This vaccine represents an advancement for child health, disease control and reduction of child mortality. In Mozambique, malaria endemic, with a prevalence of 32% in under 5 children.

Also Read: Know This: Back-to-School event focuses on Asthma education

โ€œThe introduction of the malaria vaccine into Mozambique’s childhood vaccination programme is a historic event because it is the result of research and trials carried out by Mozambican scientists in Mozambique that led to the development of the first vaccine of its kind, the RTS,S vaccine. This pioneering work laid the foundations for WHO to recommend the RTS,S and R21 vaccines for childhood immunization from 2021,โ€ Dr Severin von Xylander, WHO Representative in Mozambique

Gavi, UNICEF, WHO and other partners are supporting the Ministry of Health in the preparation, acceptance and introduction of the malaria vaccine. The support ranges from developing vaccine implementation plans, communication strategies, conducting health professional training and community engagement, and ensuring sufficient cold chain capacity.

Share This Article
Facebook Whatsapp Whatsapp LinkedIn Copy Link
Share
Previous Article Sysmex and QIAGEN Strengthen Partnership for Genetic Testing Sysmex and QIAGEN Strengthen Partnership to Advance Genetic Testing
Next Article Imperial College AHSC Names Mark Thursz as New Director Imperial College AHSC Names Mark Thursz as New Director

Recent Posts

  • From market access to national ambition, gulf healthcare is playing a longer game
  • New Push for HIV Innovation and Access Aims to Accelerate Progress Toward 2030 Goals
  • WHO Discusses Digital Health and Humanization of Care at Scientific Conference
  • Rising Ebola Cases Deepen Humanitarian Crisis for Children in DR Congo
  • Burjeel holdings secures dual credit ratings and launches USD 1.5 billion sukuk programme
  • duphat
  • MedEdge-Infinia
Two Point Five Logo white
  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: New Hope for Malaria Control: Mozambique Introduces R21 Vaccine
Share

Published by Two Point Five Media FZCO

  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: New Hope for Malaria Control: Mozambique Introduces R21 Vaccine
Share

Follow US on Social Media

Facebook Instagram Linkedin X-twitter Youtube Whatsapp
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

WhatsApp us

Logo of Medede mea
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?